180 Participants NeededMy employer runs this trial
ELV001 for Rheumatoid Arthritis
Recruiting at 27 trial locations
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Elevara Medicines Limited
Prior Safety DataThis treatment has passed at least one previous human trial
What You Need to Know Before You Apply
What is the purpose of this trial?
This is a Phase 2 randomized, double-blind, placebo-controlled study with a total duration of 32 weeks from Screening to End-of-Study (EOS) Visit. Approximately 180 participants are planned to be enrolled. The number of participants can be extended to maximally 220 to account for dropouts during the study.
Are You a Good Fit for This Trial?
Inclusion Criteria
I have signed and agreed to follow the study's rules.
I am between 18 and 75 years old.
My BMI is between 18.5 and 32, and I weigh at least 50 kg.
See 7 more
What Are the Treatments Tested in This Trial?
Interventions
- ELV001
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Placebo Group
Group I: ELV001 75 mg QDExperimental Treatment1 Intervention
Group II: ELV001 25 mg QDExperimental Treatment1 Intervention
Group III: ELV001 125 mg QDExperimental Treatment1 Intervention
Group IV: PlaceboPlacebo Group1 Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Elevara Medicines Limited
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.